New Stock News | Reports say that Legend Biotech Corp. Sponsored ADR (LEGN.US) plans to list in Hong Kong this year and raise $300 to $400 million.

20:58 12/03/2026

According to reports, Kintor Pharmaceutical (01548) joint venture Legend Biotech (LEGN.US) plans to list in Hong Kong this year, raising $300 million to $400 million (approximately HK$2.34 billion to HK$3.12 billion).

According to reports, GENSCRIPT BIO (01548) joint venture Legend Biotech Corp. Sponsored ADR (LEGN.US) plans to list in Hong Kong this year, raising between 300 million and 400 million US dollars (approximately 2.34 billion to 3.12 billion Hong Kong dollars). Legend Biotech Corp. Sponsored ADR is currently listed on the Nasdaq in the form of American Depositary Receipts. According to its official website, the company is a multinational biopharmaceutical company that integrates research and development, clinical trials, production, and commercial development of oncology immunocellular therapy, ranking at the forefront of the global immunocellular therapy field. On March 10, Legend Biotech Corp. Sponsored ADR released its performance report for 2025, with total revenue of 1.029 billion US dollars for the year, a 64% increase from 627 million US dollars in 2024. The core driver of revenue growth was the increased sales volume of its CAR-T cell therapy, CILTACABELOSONASE solution. Operating losses in 2025 narrowed to 137 million US dollars. Due to unrealized exchange losses resulting from changes in the USD to Euro exchange rate, the company's net loss expanded from 177 million US dollars in 2024 to 297 million US dollars.

YIDU TECH (02158) inventory share climbed to 4.1%, becoming the benchmark for technology stocks in the Hong Kong stock buyback market.

On March 12, IFBH (06603) spent HK$593,000 to repurchase 50,000 shares.

MOST KWAI CHUNG (01716) change of ownership, acquired by Legend Holdings Limited at a discount of approximately 42.45%, and will resume trading on March 13th.

YIDU TECH (02158) inventory share climbed to 4.1%, becoming the benchmark for technology stocks in the Hong Kong stock buyback market.

On March 12, IFBH (06603) spent HK$593,000 to repurchase 50,000 shares.

MOST KWAI CHUNG (01716) change of ownership, acquired by Legend Holdings Limited at a discount of approximately 42.45%, and will resume trading on March 13th.